Who
Gerhard F. Burbach
Director
Company insider
Files Form 4 as: Director, BWX Technologies; Director, Sight Sciences; Director, Standard BioTools; Chief Executive Officer, Thoratec; Director, Digirad.
In numbers
- Trades disclosed
- 236
- Buys
- 0
- Sells
- 32
- Bought
- $0
- Sold
- $24.9M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 17 Jan 2006
- Last trade
- 4 Sep 2026
- Last filed
- 8 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 8 Sep 2026 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —23.19 at $0.00 | filing |
| 4 Sep 2026filed 8 Sep 2026 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —23.19 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —19.62 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —19.62 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —28,261 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —28,261 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —762 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —762 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —16.96 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —16.96 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BWXT BWX TechnologiesNuclear Technology | SEC FORM 4 Sold | $414K1,983 at $208.61 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BWXT BWX TechnologiesNuclear Technology | SEC FORM 4 Sold | $414K1,983 at $208.61 | filing |
| 10 Dec 2025filed 12 Dec 2025 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —17.69 at $0.00 | filing |
| 5 Sep 2025filed 8 Sep 2025 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —19.4 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —24.57 at $0.00 | filing |
| 12 May 2025filed 14 May 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —74,766 at $0.00 | filing |
| 2 May 2025filed 6 May 2025 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —1,465 at $0.00 | filing |
| 28 Mar 2025filed 1 Apr 2025 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —28.14 at $0.00 | filing |
| 10 Dec 2024filed 12 Dec 2024 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —21.92 at $0.00 | filing |
| 5 Sep 2024filed 9 Sep 2024 | BWXT BWX Technologiesoption or derivative · Nuclear Technology | SEC FORM 4 Code A | —27.37 at $0.00 | filing |
News
BWX Technologies vs. Rocket Lab: Should You Go Nuclear or Go to Space in Your Portfolio?BWXT · fool.com · 16 Oct 2026Contrasting Leonardo DRS (NASDAQ:DRS) and BWX Technologies (NYSE:BWXT)BWXT · themarketsdaily.com · 14 Oct 2026ATI (NYSE:ATI) versus BWX Technologies (NYSE:BWXT) Head to Head ReviewBWXT · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Gerhard F. Burbach; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.